Can Recombinant Human Interferon Alpha-1b Nasal Drops Protect Medical Staff from COVID-19?

Can Recombinant Human Interferon Alpha-1b Nasal Drops Protect Medical Staff from COVID-19?

Shanghai Jiao Tong University School of Medicine recently concluded an open label, prospective, non-randomized and interventional Phase III study investigating the preventive effect of recombinant human interferon alpha nasal drops on the infection rates of COVID-19...
HCG in Bangalore to Commence Clinical Trial with Internally Developed Cytokine-Mediated Anti-COVID-19 Therapy

HCG in Bangalore to Commence Clinical Trial with Internally Developed Cytokine-Mediated Anti-COVID-19 Therapy

India’s largest private provider of cancer care, Healthcare Global Enterprises, Ltd (HCG), maintains 20 comprehensive cancer centers across India. Just days ago, HCG Bangalore lost a COVID-19 patient during a convalescent plasma procedure due to comorbidities. Now,...

Pin It on Pinterest